A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease
D Sabater-Hernández, M Sabater-Galindo… - Journal of managed …, 2016 - jmcp.org
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death worldwide
and has a substantial impact on people's health and quality of life. CVD also causes an …
and has a substantial impact on people's health and quality of life. CVD also causes an …
Role of pharmacist in cardiovascular disease‐related health promotion and in hypertension and dyslipidemia management: a cross‐sectional study in the S tate of Q …
MS El Hajj, ZR Mahfoud, J Al Suwaidi… - Journal of evaluation …, 2016 - Wiley Online Library
Rationale, aims and objectives In Q atar, cardiovascular diseases (CVD) have recently
become the leading cause of morbidity and mortality. Prevention, detection and …
become the leading cause of morbidity and mortality. Prevention, detection and …
An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease
HP Puspitasari, DSJ Costa, P Aslani, I Krass - Research in Social and …, 2016 - Elsevier
Background Community pharmacists have faced ongoing challenges in the delivery of
clinical pharmacy services. Various attitudinal and environmental factors have been found to …
clinical pharmacy services. Various attitudinal and environmental factors have been found to …
[PDF][PDF] Research in Pharmacy and Health Sciences
R Kaur, U Nautiyal, A Semwal - academia.edu
Chitosan, one of the natural multifunctional polymer, due to its unique and versatile
biological property is regarded as a useful compound in medical and pharmaceutical …
biological property is regarded as a useful compound in medical and pharmaceutical …
[引用][C] DOSSIER PHARMACEUTIQUE POUR LE SUIVI PHARMACO-THERAPEUTIQUE DES PATIENTS HYPERTENDUS EN OFFICINE
VM Henintsoa